1
|
Feng M, Qiao L, Yu Q, Liu M, Zhang J, Wen S, Li X, Teng V, Yan L, Zhang C, Li S, Guo Y, Lu P. Blood chromium and lung function among Chinese young adults: A comprehensive analysis based on epidemiology and metabolomics. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 2024; 281:116594. [PMID: 38941662 DOI: 10.1016/j.ecoenv.2024.116594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2024] [Revised: 06/10/2024] [Accepted: 06/12/2024] [Indexed: 06/30/2024]
Abstract
Chromium (Cr) exposure is associated with various respiratory system diseases, but there are limited studies investigating its impact on lung function in young adults. The Cr exposure-related metabolomic changes are not well elucidated. This study recruited 608 students from a university in Shandong Province, China in 2019. We used cohort design fitted with linear mixed-effects models to assess the association between blood Cr concentration and lung function. In addition, we performed metabolomic and lipidomic analyses of baseline serum samples (N = 582) using liquid chromatography-mass spectrometry. Two-step statistical analysis (analysis of variance and mixed-linear effect model) was used to evaluate the effect of blood Cr exposure on metabolites. We found that blood Cr was associated with decreased lung function in young adults. Each 2-fold increase in blood Cr concentrations was significantly associated with decreased FEV1 and FVC by 35.26 mL (95 % CI: -60.75, -9.78) and 38.56 mL (95 % CI: -66.60, -10.51), respectively. In the metabolomics analysis, blood Cr exposure was significantly associated with 14 key metabolites. The changed metabolites were mainly enriched in six pathways including lipid metabolism, amino acid metabolism, and cofactor vitamin metabolism. Blood Cr may affect lung function through oxidative stress and inflammation related pathways.
Collapse
Affiliation(s)
- Mingyu Feng
- Binzhou Medical University, Yantai, Shandong, China
| | - Lingyan Qiao
- Binzhou Medical University, Yantai, Shandong, China
| | - Qingxia Yu
- Binzhou Medical University, Yantai, Shandong, China
| | - Meiling Liu
- YanTaiShan Hospital, YanTai, Shandong, China
| | - Jia Zhang
- Binzhou Medical University, Yantai, Shandong, China
| | - Shuo Wen
- Binzhou Medical University, Yantai, Shandong, China
| | - Xinyuan Li
- Binzhou Medical University, Yantai, Shandong, China
| | - Victor Teng
- Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Melbourne, Australia
| | - Lailai Yan
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China
| | | | - Shanshan Li
- Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Melbourne, Australia
| | - Yuming Guo
- Binzhou Medical University, Yantai, Shandong, China; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Melbourne, Australia.
| | - Peng Lu
- Binzhou Medical University, Yantai, Shandong, China.
| |
Collapse
|
2
|
Sijko-Szpańska M, Kozłowska L. Analysis of Relationships between Metabolic Changes and Selected Nutrient Intake in Women Environmentally Exposed to Arsenic. Metabolites 2024; 14:75. [PMID: 38276310 PMCID: PMC10820439 DOI: 10.3390/metabo14010075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Revised: 01/17/2024] [Accepted: 01/20/2024] [Indexed: 01/27/2024] Open
Abstract
Nutrients involved in the metabolism of inorganic arsenic (iAs) may play a crucial role in mitigating the adverse health effects associated with such exposure. Consequently, the objective of this study was to analyze the association between the intake levels of nutrients involved in iAs metabolism and alterations in the metabolic profile during arsenic exposure. The study cohort comprised environmentally exposed women: WL (lower total urinary arsenic (As), n = 73) and WH (higher As, n = 73). The analysis included urinary untargeted metabolomics (conducted via liquid chromatography-mass spectrometry) and the assessment of nutrient intake involved in iAs metabolism, specifically methionine, vitamins B2, B6, and B12, folate, and zinc (based on 3-day dietary records of food and beverages). In the WL group, the intake of all analyzed nutrients exhibited a negative correlation with 5 metabolites (argininosuccinic acid, 5-hydroxy-L-tryptophan, 11-trans-LTE4, mevalonic acid, aminoadipic acid), while in the WH group, it correlated with 10 metabolites (5-hydroxy-L-tryptophan, dihyroxy-1H-indole glucuronide I, 11-trans-LTE4, isovalerylglucuronide, 18-oxocortisol, 3-hydroxydecanedioic acid, S-3-oxodecanoyl cysteamine, L-arginine, p-cresol glucuronide, thromboxane B2). Furthermore, nutrient intake demonstrated a positive association with 3 metabolites in the WL group (inosine, deoxyuridine, glutamine) and the WH group (inosine, N-acetyl-L-aspartic acid, tetrahydrodeoxycorticosterone). Altering the intake of nutrients involved in iAs metabolism could be a pivotal factor in reducing the negative impact of arsenic exposure on the human body. This study underscores the significance of maintaining adequate nutrient intake, particularly in populations exposed to arsenic.
Collapse
Affiliation(s)
- Monika Sijko-Szpańska
- Laboratory of Human Metabolism Research, Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences, 02776 Warsaw, Poland
| | - Lucyna Kozłowska
- Laboratory of Human Metabolism Research, Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences, 02776 Warsaw, Poland
| |
Collapse
|
3
|
Rodríguez-Carrillo A, Mustieles V, Salamanca-Fernández E, Olivas-Martínez A, Suárez B, Bajard L, Baken K, Blaha L, Bonefeld-Jørgensen EC, Couderq S, D'Cruz SC, Fini JB, Govarts E, Gundacker C, Hernández AF, Lacasaña M, Laguzzi F, Linderman B, Long M, Louro H, Neophytou C, Oberemn A, Remy S, Rosenmai AK, Saber AT, Schoeters G, Silva MJ, Smagulova F, Uhl M, Vinggaard AM, Vogel U, Wielsøe M, Olea N, Fernández MF. Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge. Int J Hyg Environ Health 2023; 249:114140. [PMID: 36841007 DOI: 10.1016/j.ijheh.2023.114140] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Revised: 02/08/2023] [Accepted: 02/15/2023] [Indexed: 02/26/2023]
Abstract
Human biomonitoring (HBM) studies have highlighted widespread daily exposure to environmental chemicals. Some of these are suspected to contribute to adverse health outcomes such as reproductive, neurological, and metabolic disorders, among other developmental and chronic impairments. One of the objectives of the H2020 European Human Biomonitoring Initiative (HBM4EU) was the development of informative effect biomarkers for application in a more systematic and harmonized way in large-scale European HBM studies. The inclusion of effect biomarkers would complement exposure data with mechanistically-based information on early and late adverse effects. For this purpose, a stepwise strategy was developed to identify and implement a panel of validated effect biomarkers in European HBM studies. This work offers an overview of the complete procedure followed, from comprehensive literature search strategies, selection of criteria for effect biomarkers and their classification and prioritization, based on toxicological data and adverse outcomes, to pilot studies for their analytical, physiological, and epidemiological validation. We present the example of one study that demonstrated the mediating role of the effect biomarker status of brain-derived neurotrophic factor BDNF in the longitudinal association between infant bisphenol A (BPA) exposure and behavioral function in adolescence. A panel of effect biomarkers has been implemented in the HBM4EU Aligned Studies as main outcomes, including traditional oxidative stress, reproductive, and thyroid hormone biomarkers. Novel biomarkers of effect, such as DNA methylation status of BDNF and kisspeptin (KISS) genes were also evaluated as molecular markers of neurological and reproductive health, respectively. A panel of effect biomarkers has also been applied in HBM4EU occupational studies, such as micronucleus analysis in lymphocytes and reticulocytes, whole blood comet assay, and malondialdehyde, 8-oxo-2'-deoxyguanosine and untargeted metabolomic profile in urine, to investigate, for example, biological changes in response to hexavalent chromium Cr(VI) exposure. The use of effect biomarkers in HBM4EU has demonstrated their ability to detect early biological effects of chemical exposure and to identify subgroups that are at higher risk. The roadmap developed in HBM4EU confirms the utility of effect biomarkers, and support one of the main objectives of HBM research, which is to link exposure biomarkers to mechanistically validated effect and susceptibility biomarkers in order to better understand the public health implications of human exposure to environmental chemicals.
Collapse
Affiliation(s)
- Andrea Rodríguez-Carrillo
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain
| | - Vicente Mustieles
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain
| | - Elena Salamanca-Fernández
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain.
| | - Alicia Olivas-Martínez
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain
| | - Beatriz Suárez
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain
| | - Lola Bajard
- RECETOX, Faculty of Science, Masaryk University, Kamenice 5, CZ62500, Brno, Czech Republic
| | - Kirsten Baken
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Ludek Blaha
- RECETOX, Faculty of Science, Masaryk University, Kamenice 5, CZ62500, Brno, Czech Republic
| | - Eva Cecilie Bonefeld-Jørgensen
- Centre for Arctic Health & Molecular Epidemiology, Department of Public Health Aarhus University, Denmark; Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland
| | - Stephan Couderq
- Physiologie Moléculaire et Adaptation, Département "Adaptation du Vivant", UMR 7221 MNHN/CNRS, Muséum National d'Histoire Naturelle, Paris, 75005, France
| | - Shereen Cynthia D'Cruz
- Univ Rennes, EHESP, Inserm, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000, Rennes, France
| | - Jean-Baptiste Fini
- Physiologie Moléculaire et Adaptation, Département "Adaptation du Vivant", UMR 7221 MNHN/CNRS, Muséum National d'Histoire Naturelle, Paris, 75005, France
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Claudia Gundacker
- Institute of Medical Genetics, Medical University of Vienna, Waehringer Strasse 10, A-1090, Vienna, Austria
| | - Antonio F Hernández
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain; Department of Legal Medicine and Toxicology, University of Granada School of Medicine, Granada, Spain
| | - Marina Lacasaña
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain; Department of Legal Medicine and Toxicology, University of Granada School of Medicine, Granada, Spain
| | - Federica Laguzzi
- Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
| | - Birgitte Linderman
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Manhai Long
- Centre for Arctic Health & Molecular Epidemiology, Department of Public Health Aarhus University, Denmark; Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland
| | - Henriqueta Louro
- National Institute of Health Doutor Ricardo Jorge (INSA), Human Genetics Department, Toxicogenomics and Human Health (ToxOmics), NOVA Medical School/FCM, Universidade Nova de Lisboa, Av. Padre Cruz, 1649-016, Lisbon, Portugal
| | | | - Axel Oberemn
- German Federal Institute for Risk Assessment, Max-Dohrn-Straße 8-10, 10589, Berlin, Germany
| | - Sylvie Remy
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | | | | | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; Department of Biomedical Sciences and Toxicological Center, University of Antwerp, Belgium
| | - Maria Joao Silva
- National Institute of Health Doutor Ricardo Jorge (INSA), Human Genetics Department, Toxicogenomics and Human Health (ToxOmics), NOVA Medical School/FCM, Universidade Nova de Lisboa, Av. Padre Cruz, 1649-016, Lisbon, Portugal
| | - Fatima Smagulova
- Univ Rennes, EHESP, Inserm, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000, Rennes, France
| | - Maria Uhl
- Environment Agency Austria (EAA), Vienna, Austria
| | - Anne Marie Vinggaard
- National Food Institute, Technical University of Denmark, 2800 Kgs, Lyngby, Denmark
| | - Ulla Vogel
- National Food Institute, Technical University of Denmark, 2800 Kgs, Lyngby, Denmark; The National Research Centre for the Working Environment, Copenhagen, Denmark
| | - Maria Wielsøe
- Centre for Arctic Health & Molecular Epidemiology, Department of Public Health Aarhus University, Denmark
| | - Nicolás Olea
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain
| | - Mariana F Fernández
- Biomedical Research Center (CIBM), University of Granada, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Spain.
| |
Collapse
|
4
|
Santonen T, Louro H, Bocca B, Bousoumah R, Duca RC, Fucic A, Galea KS, Godderis L, Göen T, Iavicoli I, Janasik B, Jones K, Leese E, Leso V, Ndaw S, Poels K, Porras SP, Ruggieri F, Silva MJ, Van Nieuwenhuyse A, Verdonck J, Wasowicz W, Tavares A, Sepai O, Scheepers PTJ, Viegas S. The HBM4EU chromates study - Outcomes and impacts on EU policies and occupational health practices. Int J Hyg Environ Health 2023; 248:114099. [PMID: 36528954 DOI: 10.1016/j.ijheh.2022.114099] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2022] [Revised: 12/02/2022] [Accepted: 12/05/2022] [Indexed: 12/23/2022]
Abstract
Within the EU human biomonitoring initiative (HBM4EU), a targeted, multi-national study on occupational exposure to hexavalent chromium (Cr(VI)) was performed. Cr(VI) is currently regulated in EU under REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) and under occupational safety and health (OSH) legislation. It has recently been subject to regulatory actions to improve its risk management in European workplaces. Analysis of the data obtained within the HBM4EU chromates study provides support both for the implementation of these regulatory actions and for national enforcement programs and may also contribute to the updating of occupational limit values (OELs) and biological limit values for Cr(VI). It also provides useful insights on the contribution of different risk management measures (RMMs) to further reduce the exposure to Cr(VI) and may support the evaluation of applications for authorisation under REACH. Findings on chrome platers' additional per- and polyfluoroalkyl substances (PFAS) exposure highlight the need to also pay attention to this substance group in the metals sector. A survey performed to evaluate the policy relevance of the HBM4EU chromates study findings supports the usefulness of the study results. According to the responses received from the survey, the HBM4EU chromates study was able to demonstrate the added value of the human biomonitoring (HBM) approach in assessment and management of occupational exposure to Cr(VI). For future occupational studies, we emphasise the need for engagement of policy makers and regulators throughout the whole research process to ensure awareness, relevance and uptake of the results in future policies.
Collapse
Affiliation(s)
- Tiina Santonen
- Finnish Institute of Occupational Health, Helsinki, Finland.
| | - Henriqueta Louro
- Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, I.P, and Centre for Toxicogenomics and Human Health (ToxOmics), NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal
| | - Beatrice Bocca
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - Radia Bousoumah
- French National Research and Safety Institute (INRS), Vandoeuvre-les-Nancy, France
| | - Radu Corneliu Duca
- Department Health Protection, Laboratoire National de Santé (LNS), Dudelange, Luxembourg; Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Leuven, Belgium
| | - Aleksandra Fucic
- Institute for Medical Research and Occupational Health, Zagreb, Croatia
| | - Karen S Galea
- Institute of Occupational Medicine (IOM), Edinburgh, UK
| | - Lode Godderis
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Leuven, Belgium; IDEWE, External Service for Prevention and Protection at Work, Heverlee, Belgium
| | - Thomas Göen
- Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
| | - Ivo Iavicoli
- Department of Public Health, University of Naples Federico II, Naples, Italy
| | - Beata Janasik
- Nofer Institute of Occupational Medicine, Lodz, Poland
| | - Kate Jones
- Health and Safety Executive, Harpur Hill, Buxton, UK
| | | | - Veruscka Leso
- Department of Public Health, University of Naples Federico II, Naples, Italy
| | - Sophie Ndaw
- French National Research and Safety Institute (INRS), Vandoeuvre-les-Nancy, France
| | - Katrien Poels
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Leuven, Belgium
| | - Simo P Porras
- Finnish Institute of Occupational Health, Helsinki, Finland
| | - Flavia Ruggieri
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - Maria J Silva
- Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, I.P, and Centre for Toxicogenomics and Human Health (ToxOmics), NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal
| | - An Van Nieuwenhuyse
- Department Health Protection, Laboratoire National de Santé (LNS), Dudelange, Luxembourg; Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Leuven, Belgium
| | - Jelle Verdonck
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Leuven, Belgium
| | | | - Ana Tavares
- Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, I.P, and Centre for Toxicogenomics and Human Health (ToxOmics), NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal
| | | | - Paul T J Scheepers
- Radboud Institute for Biological and Environmental Sciences, Radboud University, Nijmegen, the Netherlands
| | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), Lisbon, Portugal
| |
Collapse
|
5
|
Metabolic Changes and Their Associations with Selected Nutrients Intake in the Group of Workers Exposed to Arsenic. Metabolites 2023; 13:metabo13010070. [PMID: 36676995 PMCID: PMC9866863 DOI: 10.3390/metabo13010070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2022] [Revised: 12/19/2022] [Accepted: 12/27/2022] [Indexed: 01/03/2023] Open
Abstract
Arsenic (As) exposure causes numerous adverse health effects, which can be reduced by the nutrients involved in the metabolism of iAs (inorganic As). This study was carried out on two groups of copper-smelting workers: WN, workers with a urinary total arsenic (tAs) concentration within the norm (n = 75), and WH, workers with a urinary tAs concentration above the norm (n = 41). This study aimed to analyze the association between the intake level of the nutrients involved in iAs metabolism and the signal intensity of the metabolites that were affected by iAs exposure. An untargeted metabolomics analysis was carried out on urine samples using liquid chromatography-mass spectrometry, and the intake of the nutrients was analyzed based on 3-day dietary records. Compared with the WN group, five pathways (the metabolism of amino acids, carbohydrates, glycans, vitamins, and nucleotides) with twenty-five putatively annotated metabolites were found to be increased in the WH group. In the WN group, the intake of nutrients (methionine; vitamins B2, B6, and B12; folate; and zinc) was negatively associated with six metabolites (cytosine, D-glucuronic acid, N-acetyl-D-glucosamine, pyroglutamic acid, uridine, and urocanic acid), whereas in the WH group, it was associated with five metabolites (D-glucuronic acid, L-glutamic acid, N-acetyl-D-glucosamine, N-acetylneuraminic acid, and uridine). Furthermore, in the WH group, positive associations between methionine, folate, and zinc intake and the signal intensity of succinic acid and 3-mercaptolactic acid were observed. These results highlight the need to educate the participants about the intake level of the nutrients involved in iAs metabolism and may contribute to further considerations with respect to the formulation of dietary recommendations for people exposed to iAs.
Collapse
|